INM · Categories · Form 3

INM - SEC Form 3 initial insider statements

InMed Pharmaceuticals Inc. (INM) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for INM

• 13d
  New insider Adar1 Capital Management, Llc claimed ownership of 331,449 shares (SEC Form 3)

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 223d
  SEC Form 3 filed by new insider Bathery John Steven

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 229d
  SEC Form 3 filed by new insider Klompas Neil A

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 827d
  SEC Form 3 filed by new insider Jagpal Netta

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1266d
  SEC Form 3 filed by new insider Tegge Jonathan

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1282d
  SEC Form 3 filed by new insider Li Sarah

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1393d
  SEC Form 3 filed by new insider Lemerond Nicole

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1476d
  SEC Form 3 filed by new insider Baldasare Bryan T

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1517d
  SEC Form 3 filed by new insider Edwards Brenda

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1562d
  SEC Form 3 filed by new insider Grove Janet P

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1667d
  SEC Form 3: New insider Johnson Shane Aaron claimed ownership of 283,002 shares

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)

Other INM categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends